日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

快速推广应用后评估囊性纤维化调节剂疗法的长期疗效:一项双重方法研究

Miranda Afonso, Pedro; Zhou, Grace C; Su, Weiji; Burgel, Pierre-Régis; Cromwell, Elizabeth; Goss, Christopher H; Keogh, Ruth H; Liou, Theodore G; Marshall, Bruce C; Mayer-Hamblett, Nicole; Morgan, Wayne J; Ostrenga, Joshua S; Pasta, David J; Schechter, Michael S; Stanojevic, Sanja; Wainwright, Claire E; Szczesniak, Rhonda D; Andrinopoulou, Eleni-Rosalina

Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.

剑桥前列腺新辅助治疗(CANCAP03):奥拉帕尼±地加瑞克治疗原发性前列腺癌的窗口研究

Dev Harveer, Linch Mark, Narahari Krishna, Milne-Clark Toby, Cheung Melissa, Warren Anne, Malaviya Alopa, Gnanapragasam Vincent, Hernandez Tatiana, Bullock Nicholas, Machin Andrea, Dayimu Alimu, Robb Tamsin, Cromwell Elizabeth, Freeman Alex, Harrington Elizabeth A, Camacho Niedzika, Glont Silvia, Squatrito Massimo, Rotem Asaf, Moore Luiza, Hanson Robert, Dodd Marc, Anand Shubha, Kynaston Howard, Shaw Greg, Shah Nimish, Pacey Simon

Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state.

突变型 RIT1 与 YAP 协同作用,驱动肺癌发生类似 EMT 的状态。

Rominger Mary C, O'Brien Siobhan, Gupta Saksham, Moorthi Sitapriya, McSharry Maria, Kamlapurkar Shriya, Lowe Amy R, Waldum Annie, Lo April, Duke Fujiko, Wu Feinan, Headley Mark B, Cromwell Elizabeth, Glabman Raisa, Koehne Amanda, Berger Alice H

Linkage of the CF Foundation Patient Registry with the Scientific Registry of Transplant Recipients database

将囊性纤维化基金会患者登记库与移植受者科学登记库数据库进行链接

Cromwell, Elizabeth A; Ahn, Yoon Son; Johnson, Patrick J; Ramos, Kathleen J; Freeman, A Jay; Faro, Albert; Snyder, Jon J

Aging with CF: Characteristics of people with CF aged 40 and older in the United States

囊性纤维化患者的老龄化:美国40岁及以上囊性纤维化患者的特征

Ostrenga, Joshua S; Robinson, Kristina; Brown, A Whitney; Goss, Christopher H; Cromwell, Elizabeth A

Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele

囊性纤维化患者(12岁及以上,至少携带一个F508del等位基因)使用依来沙卡托/替扎沙卡托/伊伐卡托的相关因素

Hergenroeder, Georgene E; Todd, Jonathan V; Ostrenga, Josh S; Goss, Christopher H; Jain, Raksha; Morgan, Wayne; Sawicki, Gregory S; Schechter, Michael S; Cromwell, Elizabeth A; Ren, Clement L

Exploring reduced pulmonary exacerbation rates in cystic fibrosis: a pandemic or modulator effect?

探讨囊性纤维化患者肺部急性加重率降低的原因:是流行现象还是调节效应?

Stephenson, Anne L; Sykes, Jenna; Stanojevic, Sanja; Ma, Xiayi; Ostrenga, Josh; Todd, Jonathan; Faro, Al; Elbert, Alex; Marshall, Bruce; Ramos, Kathleen J; Cromwell, Elizabeth; Quon, Bradley S; Goss, Christopher H; Somayaji, Ranjani

Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data

阿奇霉素对年轻囊性纤维化患者的影响:一项利用注册数据模拟已发表的随机对照试验的方案

Granger, Emily; Todd, Jonathan; Charman, Susan Christine; Cromwell, Elizabeth; Davies, Gwyneth; Frost, Freddy; Gifford, Alex; Huang, Bin; Hamblett, Nicole Mayer; Naehrlich, Lutz; Ostrenga, Josh; Stanojevic, Sanja; Szczesniak, Rhonda; Keogh, Ruth

Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry

验证加拿大囊性纤维化登记数据的完整性和准确性

Somayaji, Ranjani; Cheng, Stephanie Y; Abdulrahem, Noma; Stanojevic, Sanja; Eckford, Paul; Quon, Bradley S; Cromwell, Elizabeth; Faro, Albert; Goss, Christopher H; Stephenson, Anne L

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA

在美国,扩大依来卡托/替扎卡托/伊伐卡托适应症对不伴有F508del变异的囊性纤维化患者的影响

Cromwell, Elizabeth A; Ostrenga, Josh S; Sanders, Don B; Morgan, Wayne; Castellani, Carlo; Szczesniak, Rhonda; Burgel, Pierre-Regis